Compare Archer Aviation Inc (ACHR) vs Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Price & Performance

Archer Aviation IncTrade

Bio-Rad Laboratories, Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Archer Aviation Inc vs Bio-Rad Laboratories, Inc. Class A Common Stock — how do they compare? Archer Aviation Inc trades at $6.81 (market cap $5.23B), while Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is the larger of the two by market cap, and Bio-Rad Laboratories, Inc. Class A Common Stock is trading nearer its 52-week high, Archer Aviation Inc nearer its low. Which is the better fit depends on your goals.

	ACHR	BIO
Market Cap	$5.23B	$9.43B
Sector	Industrials	Health
52-Week High	$13.64	$356.25
52-Week Low	$4.44	$241.71
Enterprise Value	$3.79B	$9.18B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ACHR

Archer Aviation nears commercialization with strong growth and undervalued stock despite recent gainsSeeking Alpha · 20 hours agoBullish Archer Aviation stock jumps 11% on Boeing deal details and strong Q2 revenue growth24/7 Wall Street · 23 hours agoBullish Red Cat shares jump 6.84% post-earnings despite revenue miss, driven by strong growth and sector momentum.24/7 Wall Street · 1 day agoBullish View details →

BIO

View details →

About Archer Aviation Inc

Archer Aviation develops electric vertical takeoff and landing (eVTOL) aircraft for urban air mobility. Its flagship, Midnight aircraft, is designed for air taxi services, aiming to transform urban travel with sustainable aviation.

About Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.